RecruitingNot ApplicableNCT06570057

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]: Feasibility Trial in Urban Pakistan


Sponsor

Baqai Institute of Diabetology and Endocrinology

Enrollment

240 participants

Start Date

Jun 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.


Eligibility

Min Age: 20 Years

Inclusion Criteria5

  • Individuals aged 20 years and above.
  • Participants residing in the randomized clusters of Karachi, Pakistan
  • Individuals willing to participate in the study and provide consent.
  • Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
  • Participants who can attend the scheduled meetings and interventions as per the study protocol.

Exclusion Criteria4

  • Individuals below the age of 20 years.
  • Individuals unwilling to provide consent for participation.
  • Participants with severe health conditions that may hinder their active involvement in the study.
  • Individuals with non-compliance with research protocols

Interventions

BEHAVIORALParticipatory, learning and Action (PLA) Based intervention

An PLA based intervention would be carried out to prepare the Diabetes Mellitus type II patients. The intervention would be carried out for a tentative time of 2 to 3 hours to educate the type II diabetes mellitus. The study participants would be evaluated after completion of 18 months of the intervention. A structured, validated and literature-based assessment checklist will be devised to assess the effectiveness and feasibility of the intervention.


Locations(1)

Baqai Institute of Diabetology and Endocrinology (BIDE)

Karachi, Sindh, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06570057


Related Trials